Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Pierre R. Breber

At a glance: Pierre R. Breber is Director at Clorox (CLX). Their latest SEC Form 4, filed Nov 5, 2026, reported a purchase of $400K. On file: 3 purchase lines ($1.2M) and 0 sale lines ($0).

Disclosed holdings: about $2.3M of CLX stock: 22,000 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 20, 2026 close of $106.23. This counts only CLX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Clorox Co /De/ (CLX)

Purchase track record

Strong record. Based on 2 purchases with a full 90 days of price history.

72
Avg. 90-day return+17.7%
vs. S&P 500+14.0%
Beat the market100%
Paper profit on buys+$135K
Total bought / sold$1.2M / $0

Pierre R. Breber's InsiderPrint

6 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Pierre R. Breber: 6 trades, 2025 to 20262025: 4 buys, 0 sales2026: 2 buys, 0 sales

Reading this print: Almost only buys, trading about 4 times a year, typically $429K a trade; trades in the same month most years.

  • Bump outward: a purchase (6)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. James T. Glerum Jr.Director · AMCR · 99% match
  2. Neal C. Bradsher10% Owner · IMDX · 97% match
  3. Broadwood Capital Inc10% Owner · IMDX · 97% match
  4. Broadwood Partners, L.P.10% Owner · IMDX · 97% match
  5. Matthew WilksCEO · ACDC · 97% matchTheir buys since 2023: 2 of 8 beat the S&P 500

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2025

From the SEC's insider data sets: each open-market buy by Pierre R. Breber, matched to how the stock did over the next 90 days against the S&P 500.

2 of 3 buys beat the S&P 500 (67%), median +9.2% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
CLXMay 5, 2026+9.2%
CLXNov 24, 2025+14.9%
CLXMay 9, 2025-18.8%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 5SEC CLXClorox Co /De/Past buys 2/3 beat S&P Buy 4,00022,000 held (+22%) $100.06 $400K +6.2%
May 5SEC CLXClorox Co /De/Past buys 2/3 beat S&P Buy 5,00018,000 held (+38%) $85.82 $429K +23.8%
Nov 24SEC CLXClorox Co /De/Past buys 2/3 beat S&P Buy 4,00013,000 held (+44%) $104.13 $417K +2.0%
  • Buy

    Director Pierre R Breber bought $400K of CLX at $100.06 — raises the stake by 22%.

  • Buy

    Director Pierre R Breber bought $429K of CLX at $85.82 — raises the stake by 38%.

  • Buy

    Director Pierre R Breber bought $417K of CLX at $104.13 — first open-market purchase in our records; raises the stake by 44%.

Follow Pierre R. Breber

Get one email when Pierre R. Breber files a new purchase or sale. Free.

At most one email a day about Pierre R. Breber, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.